A polymorphism in the dopamine β-hydroxylase gene is associated with “paranoid ideation” in patients with major depression

Abstract Background: Increased dopaminergic activity may play a primary role in psychotic depression. Dopamine β-hydroxylase (DβH) catalyses the key step in biosynthesis of the neurotransmitter noradrenaline from dopamine, and low DβH activity is a possible risk factor for developing psychotic depression. An exon 2 polymorphism (DBH∗444 g/a) of the DβH gene (DBH) is significantly associated with both serum and cerebrospinal fluid levels of DβH. Methods: We determined the genotype of the DBH∗444g/a polymorphism in a cohort of 164 patients with major depression and examined the association of this polymorphism with paranoid ideation, interpersonal sensitivity, and psychoticism on the Hopkins Symptom Checklist. Results: Patients who possessed the A allele were significantly more likely to have higher scores for interpersonal sensitivity and paranoia than patients without the A allele ( p = .004 and p = .048, respectively), suggesting that this allele may predispose patients to paranoia in major depression. In addition, we found an association between prolactin levels in men and DBH∗444 g/a genotype such that homozygous G individuals displayed significantly higher levels than homozygous A or heterozygote individuals. Conclusions: Depressed patients with the GG genotype of DβH have lower scores for interpersonal sensitivity and paranoid ideation. The GG genotype may be protective against the development of psychosis in the presence of a major depressive episode.

[1]  Z. Rihmer,et al.  Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression , 1986, Psychiatry Research.

[2]  D. O'Connor,et al.  CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures. , 1994, The American journal of psychiatry.

[3]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[4]  P. Joyce,et al.  Gender differences in the presentation of depressed outpatients: a comparison of descriptive variables. , 2000, Journal of affective disorders.

[5]  M. Weissman,et al.  Assessment of social adjustment by patient self-report. , 1976, Archives of general psychiatry.

[6]  T Nagatsu,et al.  Human dopamine beta-hydroxylase gene: two mRNA types having different 3'-terminal regions are produced through alternative polyadenylation. , 1989, Nucleic acids research.

[7]  R. Elston,et al.  Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. , 1988, American journal of human genetics.

[8]  A. Schatzberg,et al.  Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? , 1992, The American journal of psychiatry.

[9]  C. Ramchand,et al.  Possible control of dopamine β-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals , 1996, Human Genetics.

[10]  P. Joyce,et al.  Predictors of drug response in depression. , 1989, Archives of general psychiatry.

[11]  B. Carroll,et al.  Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients. , 1976, Archives of general psychiatry.

[12]  G. Alexopoulos,et al.  Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression , 1999, Biological Psychiatry.

[13]  M. Harrow,et al.  Psychotic unipolar depression at follow-up: factors related to psychosis in the affective disorders. , 1994, The American journal of psychiatry.

[14]  D. Rosielle,et al.  Psychiatry , 1905, NeuroImage.

[15]  R C Elston,et al.  A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. , 2001, American journal of human genetics.

[16]  P. Joyce,et al.  Social adjustment in depression: the impact of depression severity, personality, and clinic versus community sampling. , 2002, Journal of affective disorders.

[17]  R. Post,et al.  CSF dopamine beta-hydroxylase in schizophrenia. , 1983, Archives of General Psychiatry.

[18]  Stanley Friedman,et al.  DOPAMINE-β-HYDROXYLASE , 1965 .

[19]  S. Channabasavanna,et al.  Serum dopamine‐β‐hydroxylase activity in clinical subtypes of depression , 1989 .

[20]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[21]  S. Hauser,et al.  A simple method for DNA purification from peripheral blood. , 1988, Analytical biochemistry.

[22]  J. Mallet,et al.  Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. , 1988, Cytogenetics and cell genetics.

[23]  L. Covi,et al.  SCL-90: an outpatient psychiatric rating scale--preliminary report. , 1973, Psychopharmacology bulletin.

[24]  P. Sullivan,et al.  Patterns and Predictors of Remission, Response and Recovery in Major Depression Treated with Fluoxetine or Nortriptyline , 2002 .

[25]  J. Phillips,et al.  Dopamine /8‐Hydroxylase Deficiency A Genetic Disorder of Cardiovascular Regulation , 1991, Hypertension.

[26]  Cloninger Cr A systematic method for clinical description and classification of personality variants: A proposal. , 1987 .

[27]  L. Price,et al.  A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia , 2000, Molecular Psychiatry.

[28]  I. Hickie,et al.  Defining Melancholia: Properties of a Refined Sign-Based Measure , 1994, British Journal of Psychiatry.

[29]  R. Post,et al.  CSF Dopamine β-Hydroxylase in Schizophrenia: Low Activity Associated With Good Prognosis and Good Response to Neuroleptic Treatment , 1983 .

[30]  G. Winokur Psychosis in Bipolar and Unipolar Affective Illness with Special Reference to Schizo-affective Disorder , 1984, British Journal of Psychiatry.

[31]  C. Robert Cloninger A systematic method for clinical description and classification of personality variants. A proposal. , 1987, Archives of general psychiatry.

[32]  S. Channabasavanna,et al.  Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression. , 1989, Acta psychiatrica Scandinavica.

[33]  Kazuto Kobayashi,et al.  Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation , 1998, Human Genetics.

[34]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.